Skip to main content
. 2014 Oct 21;20(39):14087–14098. doi: 10.3748/wjg.v20.i39.14087

Table 2.

Effect on vertebral fracture rates (from randomized controlled trials)

Osteopenia Osteoporosis Established
Raloxifene
Alendronate NA
Risedronate NA
Ibandronate NA
Zoledronate NA
Teriparatide NA NA
Strontium ranelate
Denosumab NA

■ Denotes a preplanned analysis in the entire study population; ●Denotes a post hoc analysis. NA: No evidence available. Adapted from: Body et al[12].